Product Program year 2020 Source: CMS Open Payments

Access 2

Device Immunoassay

Open in the dashboard

General payments

$5,761,092

53 payments

Research payments

$67,195

8 payments

Through program year 2020, $5,761,092 in general payments and $67,195 in research payments were reported against Access 2 (Immunoassay).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $2,891,641 18
2020 Research $67,195 8
2019 General $2,869,452 35

Breakdown

Who paid General payments · program years 2019–2020
  1. Beckman Coulter, Inc. $5,761,092 53 payments
Top recipients General payments · program year 2020
  1. Massachusetts General Hospital Teaching hospital · MA $1,432,401 50% · 1 payment
  2. Robert Wood Johnson University Hospi Teaching hospital · NJ $1,432,401 50% · 1 payment
  3. Arshed Quyyumi Cardiovascular Disease · Atlanta, GA $7,628 <1% · 1 payment
  4. James McCord Internal Medicine · Detroit, MI $5,368 <1% · 3 payments
  5. William Peacock Emergency Medicine · Houston, TX $4,950 <1% · 2 payments

The top 5 of 11 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Cardiovascular Disease Internal Medicine $12,148 45% · 2 practitioners
  2. Emergency Medicine $9,250 34% · 2 practitioners
  3. Internal Medicine $5,368 20% · 1 practitioner
  4. Anatomic Pathology & Clinical Pathology Pathology $36 <1% · 2 practitioners
  5. Family Medicine $36 <1% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. New Jersey $1,432,401 50% · 1 recipient
  2. Massachusetts $1,432,401 50% · 1 recipient
  3. Michigan $9,668 <1% · 2 recipients
  4. Georgia $7,628 <1% · 1 recipient
  5. Ohio $4,950 <1% · 1 recipient

The top 5 of 9 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

53 general · 8 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record